NMS·Healthcare·$1.5B·#289 / 520 in Healthcare
PGEN Precigen, Inc.
40HIGH RISK
CATEGORY BREAKDOWN
GROWTH100
QUALITY42
STABILITY5
VALUATION0
GOVERNANCE52
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+146.7%
100
> 50% strong
Gross Margin
Revenue retained after direct costs
50.2%
70
> 50% strong
Cash Runway
Months of cash at current burn rate
4 months
7
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
470.0%
0
< 25% strong
Price / Sales
Market cap relative to trailing revenue
150.6x
0
< 3x strong
Rule of 40
Growth rate plus operating margin
-954
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
13.8%
73
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+19.9%
10
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE PGEN WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when PGEN's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.